Google News – Clinical Trials External News
Life Sciences & Pharma Articles
Google News – Clinical Trials External News
AI Finds New Applications in Oncologic Surgery, Drug and Biomarker Screening, and Clinical Trial Design - OncLive
Google News – Clinical Trials External News
Multiple Myeloma Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary Therapeutics, Poseida Therapeutics - Barchart.com
Google News – Clinical Trials External News
Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration - Investing News Network
Google News – Clinical Trials External News
Kailera’s obesity drug meets main goal of late-stage trials in China - PharmaLive
Google News – Clinical Trials External News
Vera Therapeutics Announces FDA Accelerated Approval of TRUTAKNA for Adults with Primary IgA Nephropathy - Quiver Quantitative
Google News – Pharmaceuticals External News
Agios Pharmaceuticals (AGIO) Sees 13.5% Surge - GuruFocus
Google News – Pharmaceuticals External News
FDA gives Vanda pediatric rare-disease designation for CMT2S therapy - Stock Titan
Google News – Pharmaceuticals External News
Why Is Agios Pharma Stock Soaring Tuesday? - Benzinga
Google News – Pharmaceuticals External News
Agios Pharmaceuticals (AGIO) Secures FDA Priority Review for Mit - GuruFocus
Google News – Pharmaceuticals External News
Opaleye management sells $4.77m Eton Pharmaceuticals (ETON) stock By Investing.com - Investing.com Canada
Google News – Pharmaceuticals External News
Vertex Pharmaceuticals to acquire Crinetics in a $10 billion deal, sending the latter's share price nearly doubling - 富途牛牛
Google News – Pharmaceuticals External News
FRTX to Acquire Crinetics Pharmaceuticals for $10 Billion - GuruFocus
Google News – Pharmaceuticals External News
Opaleye trims Eton Pharmaceuticals (ETON) stake with open-market sales - Stock Titan
Google News – Pharmaceuticals External News